Japanese men aged 36-79 years undergoing a general health check.
Conclusion: Diabetes, especially high TG-HDL diabetes, constitutes a significant risk for increased arterial stiffness and atherosclerosis. 5
Introduction
Technological advances for medical equipment have made noninvasive assessment of atherosclerosis possible in its early stages [1] . High-resolution B-mode ultrasonography is a noninvasive procedure for quantifying arterial wall thickening, and it has been shown that carotid intima-media thickness (CIMT) as measured by 5 high-resolution B-mode ultrasonography is a strong predictor of cardiovascular disease [2] . Recently the cardio-ankle vascular index (CAVI), which can evaluate arterial stiffness, was developed in Japan and has been confirmed to reflect the atherosclerotic status [3] . We reported that the CAVI was suitable for screening general populations for arterial stiffness [4] . 10
On the other hand, elevated insulin concentrations are reportedly inversely associated with serum high density lipoprotein (HDL) cholesterol concentrations [5] and positively associated with serum triglyceride (TG) concentrations [6] . Furthermore, a higher TG-HDL cholesterol ratio (TG-HDL) was found to indicate insulin resistance among general populations [7] , among overweight individuals [8, 9] , and among type2 15 diabetes [10] . We therefore classified the diabetes of our study population according to TG-HDL levels on the assumption that the diabetes of patients with high TG-HDL is mainly caused by insulin resistance with less compensatory β-cell function, while that in patients with low TG-HDL is mainly caused by absolutely β-cell dysfunction.
Several previous studies have suggested that the TG-HDL ratio is an easily obtainable atherogenic marker [11] and have shown that high TG-HDL correlates independently with the presence of angiographic coronary artery disease (defined as stenosis >50%) for both men and women even after adjustment for traditional risk 5 factors [12] , including diabetes [13] . However, no study has reported on the association, in terms of the TG-HDL ratio, between atherosclerosis/arterial stiffness, evaluated by means of CIMT and CAVI, and diabetes.
We therefore investigated the association between atherosclerosis and increased arterial stiffness evaluated by CIMT and/or CAVI on the one hand, and diabetes in terms 10 of TG-HDL levels on the other, among Japanese men who participated in a general medical check-up between 2005 and 2012.
Subjects and methods
This study was approved by the ethical committee for use of human of Nagasaki University (project registration number 0501120073).
The survey population included 1,412 men aged 30 to 79 years, all residents of the western rural community of the Goto Islands, who participated in this study between 5 2005 and 2012. A total of 68 individuals with missing data were excluded, leaving 1,344 men for enrolment in this study. There were no differences in diabetic risk factors between participants for whom data of serum measurements were available and those for whom they were not.
The mean age of the study population was 64.1 years (±9.8 SD; range 36-79). Body 10 weight and height were measured with an automatic body composition analyzer (BF-220; Tanita, Tokyo, Japan) at the time of drawing blood.
Fasting blood samples were obtained and the serum was separated and centrifuged after blood coagulation. Serum samples were also obtained in a siliconized tube. Serum TG, serum HDL, serum alanine aminotransferase (ALT), serum creatinine, and HbA 1c 15
were measured with standard laboratory procedures. 10-MHz transducer, GE Healthcare, Milwaukee, WI, USA). The protocol they used has been described in detail elsewhere [17] . The values of right and left CIMT without measurement of plaque were calculated and the higher CIMT value was used for analysis. Since a previous study reported the normal CIMT value as <1.1mm we defined atherosclerosis as CIMT≥1.1mm [18] . Intra-observer variation for CIMT (N.T., n=32) 5 was 0.91 (p<0.01), and interobserver variation (N.T. vs M.N., n=41) was 0.78 (p<0.01).
Cardio-Ankle Vascular Index (CAVI)
Brachial-ankle pulse wave velocity (PWV) is generally used to evaluate arterial stiffness. However, since one study has pointed out that PWV measurements can be 10 strongly affected by blood pressure [19] , CAVI was recently developed in Japan to avoid the susceptibility of PWV measurements to blood pressure [20] . CAVI was recorded with a Vasera VS-1000 vascular screening system (Fukuda Denshi, Tokyo, Japan) with the participant resting in a supine position. The underlying principles of CAVI have been described by Yamabe et al [21] . 15 ECG electrodes are placed on both wrists, a microphone for detecting heart sounds is placed on the sternum, and cuffs are wrapped around both arms and ankles. After measurements had been obtained automatically, data were analyzed with VSS-10 software (Fukuda Denshi) in order to calculate the values for right and left CAVI and we used the higher CAVI value for analysis. According to the manufacturer's recommendations, CAVI should be considered normal at <8, borderline at ≥8 and <9, and abnormal at ≥9. These categorize were also used by previous study [22] [23] .
Furthermore, Nakamura et al. reported that a cut-off level of 8.81 for CAVI yielded 5 maximal sensitivity and specificity for coronary artery disease [24] . We therefore adopted these values for CAVI for diagnosis of increased arterial stiffness (CAVI≥8), early atherosclerosis (8≤CAVI<9) and atherosclerosis (CAVI≥9).
Statistical analysis 10
The clinical characteristics in the present study were expressed. We established TG-HDL categories according to the tertiles of TG-HDL values for all the subjects. For the diabetic patients, differences in age-adjusted mean values for diabetic risk factors by TG-HDL category were analyzed by using covariance or general linear models, and logistic regression models were used for calculating odds ratios (ORs) and 95% 15 confidence intervals (CIs) for the association of diabetes with TG-HDL levels.
Two different approaches were used for making adjustments for confounding factors. First, the data were adjusted only for age. Second, we included other possible confounding factors, namely smoking status (never smoker, former smoker, current smoker), alcohol consumption [non-drinker, current light to moderate drinker (1-6 times/week), current heavy drinker (every day)], hypertension (no, yes), history of cardiovascular disease (no, yes), antihyperlipidemic medication use (no, yes), antidiabetic medication use (no, yes), ALT (IU/L), and estimated GFR. 5
All statistical analyses were performed with the SAS system for Windows (version 9.3; SAS Inc., Cary, NC). All p-values for statistical tests were two-tailed, and values of <0.05 were regarded as statistically significant. Prevalence of current drinkers and current smokers were 51 % and 26 %, respectively. Table 2 shows the age-adjusted characteristics of the patients divided into diabetes categories as defined by tertiles of TG-HDL for all the subjects. Diastolic blood pressure, BMI, TG and serum creatinine were found to be positively associated with TG-HDL levels and inversely associated with HDL and anti-diabetic medication use. Multivariable logistic regression analysis showed that diabetes constitutes a significant risk for increased arterial stiffness and atherosclerosis but not for early atherosclerosis. High TG-HDL diabetes constitutes a significant risk for increased 10 arterial stiffness, early atherosclerosis and atherosclerosis. However, no significant associations were observed for low and intermediate TG-HDL diabetes.
Discussion
A major finding of the present study was that diabetes, especially with high TG-HDL, represents a significant risk for atherosclerosis (CIMT≥1.1 mm) and increased arterial stiffness (CAVI ≥8.0) in Japanese men. 5
A previous randomized study reported that diabetes was characterized by a greater CIMT independently of other established risk factors for atherosclerosis [25] . A Japanese cross-sectional study reported that CAVI was a useful index of arterial stiffness and was not influenced by blood pressure changes during measurements [26] .
In a previous study we found that CAVI was an appropriate screening tool for 10 atherosclerosis and also correlated with hemoglobin A1c as significantly as did CIMT
[4].
The findings of these studies were compatible with our result that showed diabetes was a significant risk factor for atherosclerosis (CIMT≥1.1 mm, CAVI≥9) and increased arterial stiffness (CAVI≥8.0). Our TG-HDL subtype analysis showed further evidence 15 that these associations were confined to diabetic patients with high TG-HDL.
Previous studies have shown that higher TG-HDL indicates insulin resistance, [8, 9] and that high TG-HDL correlates independently with coronary artery disease even after adjustment for traditional risk factors including diabetes [12, 13] . Other previous studies reported that TG-HDL is a strong predictor for risk of myocardial infarction [27] , coronary atherosclerosis [12,13], CHD incidence [28] , cardiovascular and all causes of death [13, 29, 30] . Those studies indicate that diabetes with elevated TG-HDL indicates insulin resistance and increased arterial stiffness while diabetes with lower TG-HDL 5 indicates absence of insulin resistance and normal arterial stiffness.
Another previous study reported that early atherosclerosis was independently associated with insulin resistance in diabetic but not in non-diabetic patients [25] . Since TG-HDL is reportedly associated with insulin resistance, this study appears to support our finding that early atherosclerosis diagnosed as CAVI≥8.0 and <9 was independently 10 associated with high TG-HDL but not with low TG-HDL diabetes. Moreover, this association was also observed for atherosclerosis (CIMT≥1.1 mm, CAVI≥9) and increased arterial stiffness (CAVI ≥8.0).
The mechanisms accounting for a significant association between diabetes and arterial stiffness for diabetes with high TG-HDL only have not been elucidated. 15
Diabetes may be associated with accelerated atherosclerosis as a result of increasing the conventional risk factors, such as dyslipidemia and high blood pressure, or diabetes-specific risk factors such as advanced glycation end products (AGEs), reactive oxygen species (ROS) and matrix protein production [31] . Further, the generation of AGEs may play a key role in diabetes and cardiovascular disease, leading to chronic hyperglycemia, dyslipidemia and oxidative stress [32] . AGEs are produced when proteins and lipids undergo prolonged exposure to high glucose concentrations, which leads to loss of collagen elasticity within the walls of blood vessels and subsequent 5 reduction in arterial flexibility [33] . Furthermore, a cross-sectional study conducted in Taiwan reported that AGEs correlate more strongly with TG levels and TG/HDL when compared to glucose or correlation with the degree of insulin resistance [34] . Diabetes with high TG-HDL levels may thus indicate the presence of diabetes with high AGEs levels, which induce arterial stiffness while diabetes with low TG-HDL levels may 10 indicate diabetes with low AGEs levels, which do not induce arterial stiffness. To validate these hypotheses, further investigations using AGEs will be necessary.
Some potential limitations of this study warrant consideration. First, a number of Japanese adult participants with type1 diabetes were initially diagnosed as having type2 diabetes at disease onset [35] , and in our study type1 diabetes could not be 15 differentiated from type2 diabetes, either. However, type1 diabetes is also considered to be an independent risk factor for atherosclerosis [36] . Furthermore, intermediate TG-HDL diabetes in our study showed almost the same tendencies as low TG-HDL diabetes, a result that could not be explained only by the effect of dividing according to TG-HDL ratio for an effective differentiation between type 1 and type 2 diabetes.
Second, since data on exercise were not available, we could not make adjustments for the influence of exercise. Third, there may be a difference in patient compliance with treatment between low and high TG-HDL diabetic patients, which may affect the 5 associations between diabetes and arterial stiffness. However, our study showed such associations between TG-HDL diabetes subtypes and risk of arterial stiffness remain significant even after adjustment for use of anti-diabetic medication and anti-hyperlipidemic medication. Fourth, the small number of diabetes cases limited the robustness of our comparative analysis of the risk of increased arterial stiffness for 10 participants with high TG-HDL and low TG-HDL diabetes. However the wide difference in the confidence interval for participants with low and with high TG-HDL diabetes pointed to a significantly higher risk of increased arterial stiffness (CAVI ≥8.0) for the latter, with a multivariable OR of 6.67(1.21-36.89)(P<0.026). Nevertheless, further investigations with larger numbers of diabetic patients will be necessary. 15
Finally, because this study was a cross sectional study, we could not establish any causal relationships.
In conclusion, we found diabetes, especially in association with high TG-HDL, was a significant risk factor for atherosclerosis (CIMT≥1.1 mm) and increased arterial stiffness (CAVI ≥8.0) for Japanese men. Table 1 . Sex-specific clinical characteristics of the studied population.
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